We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Observational analysis shows that AB-101 NK cell therapy is more cost-effective than CAR-T treatments for rheumatologic diseases.
No takes yet. Share an insight, caveat, or question.
Veomett et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: